Korean J Dermatol.  1989 Oct;27(5):572-576.

A Case of Verruca Vulgaris Treated with Etretinate ( Tigason R )

Abstract

Etretinate is a synthetic retinoic acid which has been reported effective in hyperkeratotic disorders. Recently, it has also been tried, on a limited number, for the treatment of viral wart. A 33-year-old male patient presented with multiple, tender, confluent, verrucous lesions on the scalp, both hands and feet of 4 years duration. Before coming to us, he had been treated with intralesional injection of bleomycin and electrodesiccation with little effect. We started etretinate therapy in a daily dose of 70mg(1mg /kg). After 3 weeks treatment, most of his skin lesions were flattened and softened: but an abrupt elevation of serum aminotransferases was noticed, which was normalized soon after cessation of medication. Unfortunately, the drug stop page aggravated most of skin lesions. After two weeks of withdrawal we started again the drug in a daily dose of 30mg and observed a good response without hepatic dysfunction.

Keyword

Etretinate; Verruca vulgaris

MeSH Terms

Acitretin*
Adult
Bleomycin
Etretinate*
Foot
Hand
Humans
Injections, Intralesional
Male
Scalp
Skin
Transaminases
Tretinoin
Warts*
Acitretin
Bleomycin
Etretinate
Transaminases
Tretinoin
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr